Tyrosine Kinase Inhibitor

specific

A drug that interferes with cell communication and growth and may prevent tumor growth. Some tyrosine kinase inhibitors are used to treat cancer.

37

Centers

0

Active Trials

$178M

Cancer Funding

Top Centers for Tyrosine Kinase Inhibitor(37)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
Active Research Program
68.4
2
NCI Comprehensive
Active Research Program
67.4
366.5
4
NCI Comprehensive
Active Research Program
65.5
5
NCI Comprehensive
Active Research Program
64.6
6
NCI Comprehensive
Active Research Program
63.6
7
NCI Comprehensive
Active Research Program
62.7
8
NCI Comprehensive
Active Research Program
61.8
9
NCI Comprehensive
Active Research Program
60.8
10
NCI Comprehensive
Active Research Program
59.9
11
NCI Comprehensive
Active Research Program
58.9
12
Fox Chase Cancer CenterPhiladelphia, PA
NCI Comprehensive
Active Research Program
58.0
13
NCI Comprehensive
Active Research Program
57.0
14
NCI Comprehensive
Active Research Program
56.1
15
NCI Comprehensive
Active Research Program
55.1
16
Cedars-Sinai CancerLos Angeles, CA
Active Research Program
54.2
17
NCI Comprehensive
Active Research Program
53.2
18
NCI Comprehensive
Active Research Program
52.3
19
NCI Comprehensive
Active Research Program
51.4
20
NCI Comprehensive
Active Research Program
50.4
21
NCI Comprehensive
Active Research Program
49.5
22
NCI Comprehensive
Active Research Program
48.5
23
Active Research Program
47.6
24
NCI Comprehensive
Active Research Program
46.6
2545.7
26
Active Research Program
44.7
27
NCI Comprehensive
Active Research Program
43.8
28
NCI Comprehensive
Active Research Program
42.8
29
Stephenson Cancer CenterOklahoma City, OK
NCI Clinical
Active Research Program
41.9
30
NCI Comprehensive
Active Research Program
40.9
31
NCI Comprehensive
Active Research Program
40.0
32
Active Research Program
39.1
33
NCI Comprehensive
Active Research Program
38.1
34
NCI Comprehensive
Active Research Program
37.2
35
NCI Comprehensive
Active Research Program
36.2
36
NCI Clinical
Active Research Program
35.3
37
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
Contributing Research Center
34.3

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →